Candel Therapeutics, Inc. (CADL) EBITDA (2020 - 2026)
Candel Therapeutics' EBITDA came in at -$26.55 million for Q2 2026, compared with -$10.98 million a year earlier.
Powered by 
Analysis
Candel Therapeutics, Inc. (CADL) EBITDA (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Candel Therapeutics reported EBITDA of -$66.14 million; for FY2025, it was -$47.42 million.
- Going back by year, EBITDA was -$32.37 million in FY2024, -$37.39 million in FY2023, -$33.94 million in FY2022 and -$25.49 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q3 2020.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.55 Mn |
| Dec 31, 2025 | -15.61 Mn |
| Sep 30, 2025 | -13.01 Mn |
| Jun 30, 2025 | -10.98 Mn |
| Mar 31, 2025 | -7.89 Mn |
| Dec 31, 2024 | -7.89 Mn |
| Sep 30, 2024 | -8.56 Mn |
| Jun 30, 2024 | -8.37 Mn |
| Mar 31, 2024 | -7.60 Mn |
| Dec 31, 2023 | -10.03 Mn |
| Sep 30, 2023 | -8.66 Mn |
| Jun 30, 2023 | -9.34 Mn |
| Mar 31, 2023 | -9.40 Mn |
| Dec 31, 2022 | -7.92 Mn |
| Sep 30, 2022 | -8.68 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | -8.82 Mn |
| Dec 31, 2021 | -7.56 Mn |
| Sep 30, 2021 | -8.01 Mn |
| Jun 30, 2021 | -5.29 Mn |
API Access
Candel Therapeutics, Inc. EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();